ArticleRenal failure2024

Roxadustat has risks of reversible central hypothyroidism in patients undergoing hemodialysis: a single-center retrospective cohort study.

Emiko Otsuka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.